✦ LIBER ✦

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

✍ Scribed by G Ciancio; G.W Burke; K Suzart; A Vaidya; D Roth; W Kupin; A Mattiazzi; A Rosen; V Esquenazi; J Miller

Book ID: 117233133
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 59 KB
Volume: 35
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)04035-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daclizumab induction for primary kidney

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

✍ G Ciancio; A Miller; G.W Burke; H Gharagozloo; A Rosen; D Roth; W Kupin; A Pinna 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Study 2: comparison of tacrolimus and si

Study 2: comparison of tacrolimus and sirolimus combination with tacrolimus and mycophenolate mofetil in kidney transplant recipients with steroid avoidance

✍ Aparna Kumar; Daniel Lee; Sheng G. Xiao; Michael J. Moritz; Billie Fyfe; Michael 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Efficacy and cardiovascular safety of da

Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial

✍ Daniel Abramowicz; Yves Vanrenterghem; Jean-Paul Squifflet; Dirk Kuypers; Michel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Daclizumab and ATG versus ATG in combina

Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneus pancreas-kidney transplantation: analysis of early outcome

✍ K Dette; G Woeste; R Schwarz; C Wullstein; W.O Bechstein 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Pharmacokinetics, efficacy, and safety o

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients

✍ Björn Nashan; Faouzi Saliba; Francois Durand; Rafael Barcéna; Jose Ignacio Herre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepati

Safety and Efficacy of Steroid-Free Immu

Safety and Efficacy of Steroid-Free Immunosuppression with Tacrolimus and Daclizumab in Liver Transplant Recipients: 6-Year Follow-up in a Single Center

✍ B. Foroncewicz; K. Mucha; E. Ryszkowska; M. Ciszek; J. Ziółkowski; D. Porowski; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 322 KB